henledateamtoWuhanincentralChina'f sHubeiProy
More Website Templates at TemplateMonster.com!
  • hevaccineentere4

    dthesecondphaseofclinicaltrialsonApril12.Itist8

  • hefirstCOVID-19v4

    accineintheworldthatenteredthesecondphaseofclinicaltrial6

  • s,accordingtothe7

    WorldHealthOrganization. "Alargeamount Acoronavirusvaccr

  • inecandidatedeveloped2

    byaunitofChinaNationalPharmaceuticalGroup(Sj

皇冠手机app下载

vincetofighttheepiB is one of demiconthefrontline.AfM created by Templates.com team. This website template is optimized for 1024X768 screen resolution. It is also XHTML & CSS valid.

inopharm)appearedtobesafeandtriggeredantibody-basedimmuneresponsesinearlyandmid-stagetrials,researcherssaid. Thecandidatehasalreadymovedintoalate-stagetrial,oneofahandfulofcandidatesbeingtestedonseveralthousandpeopletoseeiftheyareeffectiveenoughtowinregulatoryapproval. SinopharmistestingthepotentialvaccineintheUnitedArabEmiratesinaPhase3trialexpectedtoret

cruit15,000people,asChinahastoofewnewcasestobeausefultrialsite. Thestate-ownedcompanywillalsosupplythecandidatetoPakistanaspartofatrialagreement,theWallStreetJournalreported. Theshotdidnotcauseanyserioussideeffects,accordingtoapaperpublishedonThursdayintheJourw

皇冠手机app下载

naloftheAmericanMedicalAssociation(JAMA)byscientistswhoarepartofSinopharmandotherChiny

a-baseddiseasecontrolauthoritiesandresearchinstitutes. TheresultswerebasedondatL

afrom320healthyadultsinPhase1and2trials. Thecandidatetriggeredrobustantibodyres3